Literature DB >> 19922450

The occurrence of mutations in FUS in a Belgian cohort of patients with familial ALS.

P Van Damme1, A Goris, V Race, N Hersmus, B Dubois, L Van Den Bosch, G Matthijs, W Robberecht.   

Abstract

BACKGROUND AND
PURPOSE: Mutations in fused in sarcoma (FUS) were recently identified as a cause of familial amyotrophic lateral sclerosis (ALS). The frequency of occurrence of mutations in FUS in sets of patients with familial ALS remains to be established.
METHODS: We sequenced the FUS gene in a cohort of patients with familial ALS seen at the neuromuscular clinic in Leuven. A total of 28 patients with SOD1-negative ALS from 22 families were analyzed.
RESULTS: We identified a R521H mutation in 4 patients, belonging to a kindred of dominantly inherited classical ALS. The mutation segregated with disease. Mutations in FUS were observed in 2.9% of ALS pedigrees in our cohort.
CONCLUSIONS: These results show that mutations in FUS are also a significant cause of familial ALS in Belgium.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19922450     DOI: 10.1111/j.1468-1331.2009.02859.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  21 in total

1.  De novo truncating FUS gene mutation as a cause of sporadic amyotrophic lateral sclerosis.

Authors:  Mariely DeJesus-Hernandez; Jannet Kocerha; NiCole Finch; Richard Crook; Matt Baker; Pamela Desaro; Amelia Johnston; Nicola Rutherford; Aleksandra Wojtas; Kathleen Kennelly; Zbigniew K Wszolek; Neill Graff-Radford; Kevin Boylan; Rosa Rademakers
Journal:  Hum Mutat       Date:  2010-05       Impact factor: 4.878

Review 2.  Clinical neurogenetics: amyotrophic lateral sclerosis.

Authors:  Matthew B Harms; Robert H Baloh
Journal:  Neurol Clin       Date:  2013-11       Impact factor: 3.806

Review 3.  The role of FUS gene variants in neurodegenerative diseases.

Authors:  Hao Deng; Kai Gao; Joseph Jankovic
Journal:  Nat Rev Neurol       Date:  2014-05-20       Impact factor: 42.937

4.  Fus gene mutations in familial and sporadic amyotrophic lateral sclerosis.

Authors:  Rosa Rademakers; Heather Stewart; Mariely Dejesus-Hernandez; Charles Krieger; Neill Graff-Radford; Marife Fabros; Hannah Briemberg; Neil Cashman; Andrew Eisen; Ian R A Mackenzie
Journal:  Muscle Nerve       Date:  2010-08       Impact factor: 3.217

5.  Aberrant RNA homeostasis in amyotrophic lateral sclerosis: potential for new therapeutic targets?

Authors:  Christopher J Donnelly; Jonathan C Grima; Rita Sattler
Journal:  Neurodegener Dis Manag       Date:  2014

Review 6.  Proteostasis and movement disorders: Parkinson's disease and amyotrophic lateral sclerosis.

Authors:  Daryl A Bosco; Matthew J LaVoie; Gregory A Petsko; Dagmar Ringe
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-10-01       Impact factor: 10.005

Review 7.  TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration.

Authors:  Clotilde Lagier-Tourenne; Magdalini Polymenidou; Don W Cleveland
Journal:  Hum Mol Genet       Date:  2010-04-15       Impact factor: 6.150

Review 8.  The complex molecular biology of amyotrophic lateral sclerosis (ALS).

Authors:  Rachel L Redler; Nikolay V Dokholyan
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

9.  Mutant FUS proteins that cause amyotrophic lateral sclerosis incorporate into stress granules.

Authors:  Daryl A Bosco; Nathan Lemay; Hae Kyung Ko; Hongru Zhou; Chris Burke; Thomas J Kwiatkowski; Peter Sapp; Diane McKenna-Yasek; Robert H Brown; Lawrence J Hayward
Journal:  Hum Mol Genet       Date:  2010-08-10       Impact factor: 6.150

10.  Sustained expression of TDP-43 and FUS in motor neurons in rodent's lifetime.

Authors:  Cao Huang; Pedro Yuxing Xia; Hongxia Zhou
Journal:  Int J Biol Sci       Date:  2010-07-04       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.